Genetic associations between myasthenia gravis and the HL-A system
- PMID: 1255208
- PMCID: PMC492209
- DOI: 10.1136/jnnp.39.1.23
Genetic associations between myasthenia gravis and the HL-A system
Abstract
HL-A antigens were determined in 159 myasthenic patients, 112 of whom were females and 47 males. Fifty-seven patients were thymectomized. The relationship between 23 different HL-A antigens and myasthenia gravis (MG) with reference to sex, age at onset, clinical course of MG, thymus histology, and auxiliary diseases of the patients, as well as the significance of these antigens to 245 relatives of myasthenics, were analysed. The frequencies of HL-A1 and HL-A8 were highly significantly higher in myasthenic patients than in normal Finnish controls. The increase of HL-A1 is secondary and due to a strong linkage disequilibrium between HL-A8 and HL-A1. HL-A8 appeared most often in females with onset of MG before the age of 35 years, and inpatients with thymus hyperplasia. No significant HL-A deviations were found in males or in females with later onset of disease. In seven thymoma patients the occurrence of W10 antigen was almost significantly increased.
Similar articles
-
LD antigens associated with HL-A8 and myasthenia gravis.Tissue Antigens. 1975 Oct;6(4):175-82. doi: 10.1111/j.1399-0039.1975.tb00632.x. Tissue Antigens. 1975. PMID: 53901
-
The biologic significance of HL-A antigen markers in myasthenia gravis.Ann N Y Acad Sci. 1976;274:440-50. doi: 10.1111/j.1749-6632.1976.tb47705.x. Ann N Y Acad Sci. 1976. PMID: 1066993 No abstract available.
-
HL-A antigens, autoantibody production, and associated diseases in thymoma patients, with and without myasthenia gravis.Ann N Y Acad Sci. 1976;274:468-74. doi: 10.1111/j.1749-6632.1976.tb47708.x. Ann N Y Acad Sci. 1976. PMID: 1085589
-
On the significance of HL-A and LD antigens in myasthenia gravis.Ann N Y Acad Sci. 1976;274:451-60. doi: 10.1111/j.1749-6632.1976.tb47706.x. Ann N Y Acad Sci. 1976. PMID: 134661 Review. No abstract available.
-
The role of thymomas in the development of myasthenia gravis.Ann N Y Acad Sci. 2003 Sep;998:223-36. doi: 10.1196/annals.1254.025. Ann N Y Acad Sci. 2003. PMID: 14592880 Review.
Cited by
-
The immunogenetics of neurological disease.Immunology. 2018 Apr;153(4):399-414. doi: 10.1111/imm.12869. Epub 2017 Dec 11. Immunology. 2018. PMID: 29159928 Free PMC article. Review.
-
Risk for myasthenia gravis maps to a (151) Pro→Ala change in TNIP1 and to human leukocyte antigen-B*08.Ann Neurol. 2012 Dec;72(6):927-35. doi: 10.1002/ana.23691. Epub 2012 Oct 10. Ann Neurol. 2012. PMID: 23055271 Free PMC article.
-
Late onset myasthenia gravis is associated with HLA DRB1*15:01 in the Norwegian population.PLoS One. 2012;7(5):e36603. doi: 10.1371/journal.pone.0036603. Epub 2012 May 9. PLoS One. 2012. PMID: 22590574 Free PMC article. Clinical Trial.
-
Association of myasthenia gravis and polymyositis with neoplasia, infection and autoimmune disorders.Acta Neuropathol. 1982;57(2-3):221-9. doi: 10.1007/BF00685393. Acta Neuropathol. 1982. PMID: 6751015 No abstract available.
-
Immune disease and HLA associations with myasthenia gravis.J Neurol Neurosurg Psychiatry. 1980 Jul;43(7):611-21. doi: 10.1136/jnnp.43.7.611. J Neurol Neurosurg Psychiatry. 1980. PMID: 6967515 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials